Experimental Ebola vaccine appears safe, prompts immune response
Thursday, November 27, 2014 - 15:30
in Health & Medicine
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial.
